US FDA expands approval of Roche hemophilia drug
Roche is looking to capture a big share of a $ 10 billion-per-year hemophilia market from established rivals like Shire, Bayer AG…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.